These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3500654)

  • 1. Propofol infusion for coronary artery bypass surgery in a patient with suspected malignant hyperpyrexia.
    Richardson J
    Anaesthesia; 1987 Oct; 42(10):1125. PubMed ID: 3500654
    [No Abstract]   [Full Text] [Related]  

  • 2. Propofol during cardiopulmonary bypass in a patient susceptible to malignant hyperpyrexia.
    Marks LF; Edwards JC; Linter SP
    Anaesth Intensive Care; 1988 Nov; 16(4):482-5. PubMed ID: 3266064
    [No Abstract]   [Full Text] [Related]  

  • 3. Propofol-fentanyl anaesthesia for coronary artery surgery and cardiopulmonary bypass.
    Russell GN; Wright EL; Fox MA; Douglas EJ; Cockshott ID
    Anaesthesia; 1989 Mar; 44(3):205-8. PubMed ID: 2784950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propofol in patients susceptible to malignant hyperpyrexia.
    Cartwright DP
    Anaesthesia; 1989 Feb; 44(2):173. PubMed ID: 2784640
    [No Abstract]   [Full Text] [Related]  

  • 5. Propofol-fentanyl anaesthesia for coronary bypass surgery in patients with good left ventricular function.
    Vermeyen KM; Erpels FA; Janssen LA; Beeckman CP; Hanegreefs GH
    Br J Anaesth; 1987 Sep; 59(9):1115-20. PubMed ID: 3499162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The screening of propofol in MHS swine.
    Raff M; Harrison GG
    Anesth Analg; 1989 Jun; 68(6):750-1. PubMed ID: 2786680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propofol and malignant hyperpyrexia.
    Denborough M; Hopkinson KC
    Lancet; 1988 Jan; 1(8578):191. PubMed ID: 2893036
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of propofol on cardiovascular dynamics, myocardial blood flow and myocardial metabolism in patients with coronary artery disease.
    Stephan H; Sonntag H; Schenk HD; Kettler D; Khambatta HJ
    Br J Anaesth; 1986 Sep; 58(9):969-75. PubMed ID: 3489478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the myocardial metabolic and haemodynamic changes produced by propofol-sufentanil and enflurane-sufentanil anaesthesia for patients having coronary artery bypass graft surgery.
    Hall RI; Murphy JT; Moffitt EA; Landymore R; Pollak PT; Poole L
    Can J Anaesth; 1991 Nov; 38(8):996-1004. PubMed ID: 1836422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of anesthetic induction agents in patients with coronary artery disease and left ventricular dysfunction.
    Singh R; Choudhury M; Kapoor PM; Kiran U
    Ann Card Anaesth; 2010; 13(3):217-23. PubMed ID: 20826962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of halothane, isoflurane, sevoflurane and propofol infusion on renal function after coronary artery bypass surgery.
    Saricaoğlu F; Akinci SB; Oç B; Kanbak M; Akbulut B; Celebioglu B
    Middle East J Anaesthesiol; 2006 Jun; 18(5):955-64. PubMed ID: 17094535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of bispectral index monitoring on stress response and propofol consumption in patients undergoing coronary artery bypass surgery.
    Bauer M; Wilhelm W; Kraemer T; Kreuer S; Brandt A; Adams HA; Hoff G; Larsen R
    Anesthesiology; 2004 Nov; 101(5):1096-104. PubMed ID: 15505444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propofol in patients susceptible to malignant hyperthermia: a case report and review of the literature.
    Mathews EL; Dhamee MS
    J Clin Anesth; 1992; 4(4):331-2. PubMed ID: 1358135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stability of myocardial perfusion during revascularization under propofol anesthesia].
    Sindelić R; Vlajković G; Ristić M
    Acta Chir Iugosl; 2001; 48(2):13-7. PubMed ID: 11889972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Difficult tracheal intubation in a patient suspected of malignant hyperthermia].
    Nikaido Y; Murao K; Ikeda S; Sakamoto S; Uchiyama Y; Shingu K
    Masui; 2003 Feb; 52(2):162-4. PubMed ID: 12649873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total intravenous anesthesia with a propofol-ketamine combination during coronary artery surgery.
    Botero CA; Smith CE; Holbrook C; Chavez AM; Snow NJ; Hagen JF; Pinchak AC
    J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):409-15. PubMed ID: 10972606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized open-label phase I pilot study of the safety and efficacy of total intravenous anesthesia with fospropofol for coronary artery bypass graft surgery.
    Fechner J; Ihmsen H; Schüttler J; Jeleazcov C
    J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):908-15. PubMed ID: 24054187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case conference 3--1990. Two patients develop some signs and symptoms of malignant hyperthermia during cardiac surgery with cardiopulmonary bypass--is it the real thing.
    Kleinman B; Kalathiveetil J; Jain U; Blakeman B; Glisson S; D'Ambra MN; Donovan C; Harrell G; Kaplan DK; Akins CW
    J Cardiothorac Anesth; 1990 Jun; 4(3):385-99. PubMed ID: 1983406
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhalation versus intravenous anaesthesia for adults undergoing on-pump or off-pump coronary artery bypass grafting: A systematic review and meta-analysis of randomized controlled trials.
    El Dib R; Guimarães Pereira JE; Agarwal A; Gomaa H; Ayala AP; Botan AG; Braz LG; de Oliveira LD; Lopes LC; Mathew PJ
    J Clin Anesth; 2017 Aug; 40():127-138. PubMed ID: 28625437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of alfentanil, fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery.
    Ahonen J; Olkkola KT; Hynynen M; Seppälä T; Ikävalko H; Remmerie B; Salmenperä M
    Br J Anaesth; 2000 Oct; 85(4):533-40. PubMed ID: 11064610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.